EIDD-1723
http://dbpedia.org/resource/EIDD-1723 an entity of type: Thing
EIDD-1723, also known as EPRX-01723 or as progesterone 20E-[O-[(phosphonooxy)methyl]oxime] sodium salt, is a synthetic, water-soluble analogue of progesterone and a neurosteroid which was developed for the potential treatment of traumatic brain injury. It is a rapidly converted prodrug of EIDD-036 (EPRX-036; progesterone 20-oxime), which is considered to be the active form of the agent. Previous C3 and C20 oxime derivatives of progesterone, such as P1-185 (progesterone 3-O-(L-valine)-E-oxime), were also developed and studied prior to EIDD-1723.
rdf:langString
rdf:langString
EIDD-1723
xsd:integer
57000496
xsd:integer
1084540411
xsd:integer
22
xsd:integer
1659302
xsd:integer
32
rdf:langString
Pregn-4-ene-3,20-dione 20E-[O-[methyl]oxime] sodium salt
xsd:integer
1
xsd:integer
2
xsd:integer
6
xsd:integer
1
rdf:langString
C/C=N\OCOP=O.[Na+].[Na+]
xsd:integer
1
rdf:langString
SXDGHAWSHQZKQM-ZZSMYOISSA-L
rdf:langString
Progesterone 20E-[O-[methyl]oxime] sodium salt; Pregn-4-ene-3,20-dione 20E-[O-[methyl]oxime] sodium salt
xsd:integer
250
rdf:langString
EIDD-1723, also known as EPRX-01723 or as progesterone 20E-[O-[(phosphonooxy)methyl]oxime] sodium salt, is a synthetic, water-soluble analogue of progesterone and a neurosteroid which was developed for the potential treatment of traumatic brain injury. It is a rapidly converted prodrug of EIDD-036 (EPRX-036; progesterone 20-oxime), which is considered to be the active form of the agent. Previous C3 and C20 oxime derivatives of progesterone, such as P1-185 (progesterone 3-O-(L-valine)-E-oxime), were also developed and studied prior to EIDD-1723.
xsd:nonNegativeInteger
4475
xsd:string
1659302-89-2